EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ibrutinib-loaded potato starch nanoparticles conjugated with melatonin for colorectal cancer therapy: in silico and in vitro evaluation of therapeutic potential and translational prospects

Yash Dhananand Sonawane, Sankha Bhattacharya

RSC Pharmaceutics · 2026

DOI: 10.1039/d6pm00474a ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Yash Dhananand Sonawane und 1 weiteren Autor:innen. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In HT-29 colorectal cancer cells, melatonin-conjugated potato starch nanoparticles of ibrutinib facilitate pH and enzyme-responsive ibrutinib administration, improving cellular uptake and death while lowering inflammatory cytokines.

Zitieren

APA

Sonawane, Y. D., & Bhattacharya, S. (2026). Ibrutinib-loaded potato starch nanoparticles conjugated with melatonin for colorectal cancer therapy: in silico and in vitro evaluation of therapeutic potential and translational prospects. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00474a

Vancouver

Sonawane YD, Bhattacharya S. Ibrutinib-loaded potato starch nanoparticles conjugated with melatonin for colorectal cancer therapy: in silico and in vitro evaluation of therapeutic potential and translational prospects. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00474a

BibTeX
@article{Sonawane2026,
  author = {Sonawane, Yash Dhananand and Bhattacharya, Sankha},
  title = {Ibrutinib-loaded potato starch nanoparticles conjugated with melatonin for colorectal cancer therapy: in silico and in vitro evaluation of therapeutic potential and translational prospects},
  journal = {RSC Pharmaceutics},
  year = {2026},
  doi = {10.1039/d6pm00474a}
}
Kostenlos starten →